-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Omada Health, Lowers Price Target to $26

Benzinga·03/12/2026 18:58:48
Listen to the news
JP Morgan analyst Destiny Jackson maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $32 to $26.